Invention Grant
- Patent Title: Techniques for modelling and optimizing dialysis toxin displacer compounds
-
Application No.: US17162030Application Date: 2021-01-29
-
Publication No.: US11640846B2Publication Date: 2023-05-02
- Inventor: Xia Tao , Vaibhav Maheshwari , Peter Kotanko , Stephan Thijssen , Nadja Grobe
- Applicant: Fresenius Medical Care Holdings, Inc.
- Applicant Address: US MA Waltham
- Assignee: Fresenius Medical Care Holdings, Inc.
- Current Assignee: Fresenius Medical Care Holdings, Inc.
- Current Assignee Address: US MA Waltham
- Agency: KDW Firm PLLC
- Main IPC: G16B15/30
- IPC: G16B15/30 ; A61M1/16 ; G16H20/17 ; G16H20/40 ; G16H50/50 ; G16B5/20 ; G16C20/30 ; G16C20/64

Abstract:
Systems, methods, and/or apparatuses may be operative to perform a dialysis process that includes a displacer infusion process. In one embodiment, a method for determining a displacer compound may include constructing a plurality of target protein quantitative structure-activity relationship (QSAR) models, one for each of the plurality of binding sites, analyzing a set of candidate compounds using the plurality of QSAR models to determine a set of at least one potential compound with an affinity for binding to each of the plurality of binding sites, and selecting at least one displacer compound from the set of at least one potential compound. Other embodiments are described.
Public/Granted literature
- US20210241848A1 TECHNIQUES FOR MODELLING AND OPTIMIZING DIALYSIS TOXIN DISPLACER COMPOUNDS Public/Granted day:2021-08-05
Information query